Physician
Merens, Teri
Merens, Teri was paid $106K by Medicaid between Jan 2018 and Dec 2024, across 16 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 57% of everything it billed.
33Billing provider infoMERENS, TERI
EVANSTON, IL 60202
EVANSTON, IL 60202
33aNPI1174523625assigned 07/27/2005
33bProvider typePediatrics Physician
28Total paid$106K
24GClaims2,739
24DCodes billed16
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Illinois
Rank by total paid#714 of 1,805
Median peer was paid$55K
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 309 | $10K | |
| 2019 | 259 | $11K | |
| 2020 | 463 | $14K | |
| 2021 | 263 | $8K | |
| 2022 | 540 | $23K | |
| 2023 | 459 | $19K | |
| 2024incomplete | 446 | $22K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 57% | 1,227 | 1,069 | $60K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 324 | 293 | $22K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.9% | 142 | 130 | $6K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.8% | 67 | 58 | $5K |
| 90686 | 3.6% | 323 | 270 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.3% | 48 | 46 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.4% | 57 | 42 | $1K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.3% | 84 | 67 | $1K |
| 90656 | 1.2% | 74 | 63 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 31 | 28 | $900.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 35 | 30 | $360.64 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 16 | 15 | $313.00 |
4 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.